News

‘ResiClub’ compiled both public and private mortgage rate forecasts for the end of 2025. Here’s where they predict rates will go.

Cantor initiated coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company with five commercialized products. The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate for severe allergic reactions, including anaphylaxis, and an earlier-stage epinephrine prodrug topical gel for various dermatology conditions. Cantor highlights that th

U.S. equities were lower in early afternoon trading, with the Dow Jones Industrial Average losing streak continuing and the Nasdaq falling from its record high yesterday.

Amentum Holdings swung to a fourth-quarter profit but shares sank Tuesday when executives said in the company's earnings call that they see fiscal 2025 growth being affected by an expected winding down of certain government programs.

LONDON (Reuters) -International and domestic insurers are pushing into the U.S. market for hard-to-protect homes, charging high premiums and enjoying strong profits after some U.S. firms pulled out. This has left greater room for non-domestic players like Hiscox and Munich Re to enter the fray, industry sources say. Recent large U.S. hurricanes Helene and Milton have added to concern about property losses.

Retail investors poured nearly $11 million into MicroStrategy's shares on Monday, almost three times their average daily inflows this year, after the biggest corporate holder of bitcoin secured a spot in the Nasdaq-100 index. The data, compiled by Vanda Research on Tuesday, highlights the bitcoin bull's growing popularity among individual investors after its stock notched an eye-popping return of nearly 550%, outpacing Wall Street favorite Nvidia's roughly 160% surge so far in 2024. Promoted as a financial tool free of government intermediaries, bitcoin often earns its corporate champions a devoted following.

The performance gap between the cap-weighted S&P 500 — tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY) — and its equal-weighted sibling, the Invesco S&P 500 Equal Weight ETF (NYSE:RSP), has blown out to over 4 percentage points in December. This marks the widest monthly gap since May 2023, reflecting how a narrow group of stocks is shouldering the market's returns in the last month of the year. As of Dec. 17, only 90 out of 500 stocks in the S&P 500 are in positive territory month-to-date, a sh